ENHO and EDN1 variants link adropin-endothelin-1 imbalance with early vascular aging in adults with and without type 2 diabetes.
- 1Department of Biochemistry, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur, Tamil Nadu, India.
- 2Department of General Medicine, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
Abstract
Background
Early vascular aging (EVA) is common in type 2 diabetes, yet its inherited determinants remain undefined. This study examined the associations of ENHO and EDN1 genetic variation with circulating adropin, endothelin-1, their relative imbalance, and early vascular aging in adults with and without T2DM.Methods
This study included 300 adults aged 25-55 years, comprising 150 participants with T2DM and 150 age- and sex-matched controls. Participants were further classified as having Early vascular aging (EVA) (n=116) or Normal vascular aging (NVA) (n=184) using age-referenced estimated pulse wave velocity. ENHO rs2281997 and rs72735260, and EDN1 rs5370 and rs2070699 were genotyped by HRM analysis with Sanger confirmation. Gene-specific and total genetic risk scores (GRS) were tested against adropin, endothelin-1, the adropin-endothelin-1 imbalance index (AEI), EVA, and continuous ePWV.Results
In the overall cohort, all four variants were associated with EVA in the risk direction. rs5370 and rs72735260 remained significant after FDR correction. Each additional risk allele in the Total GRS increased the adjusted odds of EVA by 69% (OR 1.691, 95% CI 1.381-2.094), with a graded increase across genetic burden categories. Higher ENHO-GRS was associated with lower adropin, higher EDN1-GRS with higher endothelin-1, and higher Total GRS with greater AEI, which statistically mediated 51.8% of the GRS-EVA association. Within the study cohort, AEI discriminated EVA better than GRS (AUC 0.776 vs 0.661).Conclusions
Combined ENHO-EDN1 genetic burden is associated with an adverse adropin-endothelin-1 balance and early vascular aging. Independent replication is required before clinical application.
Related
- Albuminuria, kidney function, and automatically quantified retinal vascular phenotypes in hospitalized adults with type 2 diabetes
- Effects of Laparoscopic Sleeve Gastrectomy on Vascular and Myocardial Recovery: Type 2 Diabetes and Echocardiographic Indices of Diastolic Function
- Serum Osteopontin Is Associated with Cardio-Ankle Vascular Index-Defined Arterial Stiffness in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study
- Dietary inflammatory index in relation to metabolic health status, serum levels of brain-derived neurotrophic factor and adropin in Iranian adults
- SGLT2 Inhibitors as Endothelial Protectors: Mechanisms of Vascular Restoration in Type 2 Diabetes
BibTeX
@article{sivakumar2026enho,
title = {{ENHO and EDN1 variants link adropin-endothelin-1 imbalance with early vascular aging in adults with and without type 2 diabetes.}},
author = {Rooban Sivakumar and K A Arul Senghor and V M Vinodhini and Janardhanan Kumar},
journal = {Frontiers in endocrinology},
year = {2026},
month = oct,
doi = {10.3389/fendo.2026.1961984},
url = {https://europepmc.org/article/MED/42903113},
note = {CC BY},
}
RIS
TY - JOUR
TI - ENHO and EDN1 variants link adropin-endothelin-1 imbalance with early vascular aging in adults with and without type 2 diabetes.
AU - Rooban Sivakumar
AU - K A Arul Senghor
AU - V M Vinodhini
AU - Janardhanan Kumar
PY - 2026
DA - 2026/10/06
JO - Frontiers in endocrinology
DO - 10.3389/fendo.2026.1961984
UR - https://europepmc.org/article/MED/42903113
AB - Background Early vascular aging (EVA) is common in type 2 diabetes, yet its inherited determinants remain undefined. This study examined the associations of ENHO and EDN1 genetic variation with circulating adropin, endothelin-1, their relative imbalance, and early vascular aging in adults with and without T2DM.Methods This study included 300 adults aged 25-55 years, comprising 150 participants with T2DM and 150 age- and sex-matched controls. Participants were further classified as having Early vascular aging (EVA) (n=116) or Normal vascular aging (NVA) (n=184) using age-referenced estimated pulse wave velocity. ENHO rs2281997 and rs72735260, and EDN1 rs5370 and rs2070699 were genotyped by HRM analysis with Sanger confirmation. Gene-specific and total genetic risk scores (GRS) were tested against adropin, endothelin-1, the adropin-endothelin-1 imbalance index (AEI), EVA, and continuous ePWV.Results In the overall cohort, all four variants were associated with EVA in the risk direction. rs5370 and rs72735260 remained significant after FDR correction. Each additional risk allele in the Total GRS increased the adjusted odds of EVA by 69% (OR 1.691, 95% CI 1.381-2.094), with a graded increase across genetic burden categories. Higher ENHO-GRS was associated with lower adropin, higher EDN1-GRS with higher endothelin-1, and higher Total GRS with greater AEI, which statistically mediated 51.8% of the GRS-EVA association. Within the study cohort, AEI discriminated EVA better than GRS (AUC 0.776 vs 0.661).Conclusions Combined ENHO-EDN1 genetic burden is associated with an adverse adropin-endothelin-1 balance and early vascular aging. Independent replication is required before clinical application.
SN - 1664-2392
ER -